Return On Assets of Panbela Therapeutics, Inc. from 30 Sep 2013 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Panbela Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2013 to 30 Sep 2024.
  • Panbela Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2024 was -302%, a 66% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2023 was -173%, a 66% increase from 2022.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2022 was -508%, a 450% decline from 2021.
  • Panbela Therapeutics, Inc. annual Return On Assets for 2021 was -92%, a 30% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Panbela Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -302% -120% -66% 01 Jul 2024 30 Sep 2024
Q2 2024 -270% -95% -54% 01 Apr 2024 30 Jun 2024
Q1 2024 -208% +235% +53% 01 Jan 2024 31 Mar 2024
Q4 2023 -173% +335% +66% 01 Oct 2023 31 Dec 2023
Q3 2023 -182% +199% +52% 01 Jul 2023 30 Sep 2023
Q2 2023 -175% +103% +37% 01 Apr 2023 30 Jun 2023
Q1 2023 -443% -342% -341% 01 Jan 2023 31 Mar 2023
Q4 2022 -508% -416% -450% 01 Oct 2022 31 Dec 2022
Q3 2022 -381% -308% -420% 01 Jul 2022 30 Sep 2022
Q2 2022 -278% -203% -272% 01 Apr 2022 30 Jun 2022
Q1 2022 -100% -38% -61% 01 Jan 2022 31 Mar 2022
Q4 2021 -92% -21% -30% 01 Oct 2021 31 Dec 2021
Q3 2021 -73% +24% +24% 01 Jul 2021 30 Sep 2021
Q2 2021 -75% +72% +49% 01 Apr 2021 30 Jun 2021
Q1 2021 -62% +184% +75% 01 Jan 2021 31 Mar 2021
Q4 2020 -71% +172% +71% 01 Oct 2020 31 Dec 2020
Q3 2020 -97% +169% +64% 01 Jul 2020 30 Sep 2020
Q2 2020 -147% +215% +59% 01 Apr 2020 30 Jun 2020
Q1 2020 -246% +118% +32% 01 Jan 2020 31 Mar 2020
Q4 2019 -243% +137% +36% 01 Oct 2019 31 Dec 2019
Q3 2019 -266% +310% +54% 01 Jul 2019 30 Sep 2019
Q2 2019 -362% +175% +33% 01 Apr 2019 30 Jun 2019
Q1 2019 -364% +73% +17% 01 Jan 2019 31 Mar 2019
Q4 2018 -380% +198% +34% 01 Oct 2018 31 Dec 2018
Q3 2018 -576% -4% -0.76% 01 Jul 2018 30 Sep 2018
Q2 2018 -537% +18% +3.3% 01 Apr 2018 30 Jun 2018
Q1 2018 -437% +77% +15% 01 Jan 2018 31 Mar 2018
Q4 2017 -577% -243% -73% 01 Oct 2017 31 Dec 2017
Q3 2017 -572% -365% -176% 01 Jul 2017 30 Sep 2017
Q2 2017 -556% -375% -208% 01 Apr 2017 30 Jun 2017
Q1 2017 -514% -251% -96% 01 Jan 2017 31 Mar 2017
Q4 2016 -334% +122% +27% 01 Oct 2016 31 Dec 2016
Q3 2016 -207% +300% +59% 01 Jul 2016 30 Sep 2016
Q2 2016 -180% +634% +78% 01 Apr 2016 30 Jun 2016
Q1 2016 -263% +377% +59% 01 Jan 2016 31 Mar 2016
Q4 2015 -456% -64% -16% 01 Oct 2015 31 Dec 2015
Q3 2015 -507% -175% -53% 01 Jul 2015 30 Sep 2015
Q2 2015 -815% -755% -1262% 01 Apr 2015 30 Jun 2015
Q1 2015 -640% -587% -1109% 01 Jan 2015 31 Mar 2015
Q4 2014 -393% -354% -919% 01 Oct 2014 31 Dec 2014
Q3 2014 -331% -324% -4594% 01 Jul 2014 30 Sep 2014
Q2 2014 -60% 01 Apr 2014 30 Jun 2014
Q1 2014 -53% 01 Jan 2014 31 Mar 2014
Q4 2013 -39% 01 Oct 2013 31 Dec 2013
Q3 2013 -7% 01 Jul 2013 30 Sep 2013

Panbela Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -173% +335% +66% 01 Jan 2023 31 Dec 2023
2022 -508% -416% -450% 01 Jan 2022 31 Dec 2022
2021 -92% -21% -30% 01 Jan 2021 31 Dec 2021
2020 -71% +172% +71% 01 Jan 2020 31 Dec 2020
2019 -243% +137% +36% 01 Jan 2019 31 Dec 2019
2018 -380% +198% +34% 01 Jan 2018 31 Dec 2018
2017 -577% -243% -73% 01 Jan 2017 31 Dec 2017
2016 -334% +122% +27% 01 Jan 2016 31 Dec 2016
2015 -456% -64% -16% 01 Jan 2015 31 Dec 2015
2014 -393% -354% -919% 01 Jan 2014 31 Dec 2014
2013 -39% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.